Fusion to a highly charged proteasomal retargeting sequence increases soluble cytoplasmic expression and efficacy of diverse anti-synuclein intrabodies

References

• Miller TW, Messer A. Intrabody applications in neurological disorders: progress and future prospects. Mol Ther 2005; 12:394 - 401; http://dx.doi.org/10.1016/j.ymthe.2005.04.003; PMID: 15964243
   PubMed Web of Science ®Google Scholar
• Messer A, Lynch SM, Butler DC. Developing intrabodies for the therapeutic suppression of neurodegenerative pathology. Expert Opin Biol Ther 2009; 9:1189 - 97; http://dx.doi.org/10.1517/14712590903176387; PMID: 19653865
   PubMed Web of Science ®Google Scholar
• Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotný J, Margolies MN, et al. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A 1988; 85:5879 - 83; http://dx.doi.org/10.1073/pnas.85.16.5879; PMID: 3045807
   PubMed Web of Science ®Google Scholar
• Butler DC, McLear JA, Messer A. Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins. Prog Neurobiol 2012; 97:190 - 204; http://dx.doi.org/10.1016/j.pneurobio.2011.11.004; PMID: 22120646
   PubMed Web of Science ®Google Scholar
• Kvam E, Sierks MR, Shoemaker CB, Messer A. Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm. Protein Eng Des Sel 2010; 23:489 - 98; http://dx.doi.org/10.1093/protein/gzq022; PMID: 20378699
   PubMed Web of Science ®Google Scholar
• Ellis RJ. Macromolecular crowding: an important but neglected aspect of the intracellular environment. Curr Opin Struct Biol 2001; 11:114 - 9; http://dx.doi.org/10.1016/S0959-440X(00)00172-X; PMID: 11179900
   PubMed Web of Science ®Google Scholar
• Wörn A, Plückthun A. An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly. FEBS Lett 1998; 427:357 - 61; http://dx.doi.org/10.1016/S0014-5793(98)00463-3; PMID: 9637257
   PubMed Web of Science ®Google Scholar
• Rechsteiner M, Rogers SW. PEST sequences and regulation by proteolysis. Trends Biochem Sci 1996; 21:267 - 71; PMID: 8755249
   PubMed Web of Science ®Google Scholar
• Rogers S, Wells R, Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 1986; 234:364 - 8; http://dx.doi.org/10.1126/science.2876518; PMID: 2876518
   PubMed Web of Science ®Google Scholar
• Butler DC, Messer A. Bifunctional anti-huntingtin proteasome-directed intrabodies mediate efficient degradation of mutant huntingtin exon 1 protein fragments. PLoS One 2011; 6:e29199; http://dx.doi.org/10.1371/journal.pone.0029199; PMID: 22216210
   PubMed Web of Science ®Google Scholar
• Emadi S, Barkhordarian H, Wang MS, Schulz P, Sierks MR. Isolation of a human single chain antibody fragment against oligomeric alpha-synuclein that inhibits aggregation and prevents alpha-synuclein-induced toxicity. J Mol Biol 2007; 368:1132 - 44; http://dx.doi.org/10.1016/j.jmb.2007.02.089; PMID: 17391701
   PubMed Web of Science ®Google Scholar
• Emadi S, Kasturirangan S, Wang MS, Schulz P, Sierks MR. Detecting morphologically distinct oligomeric forms of alpha-synuclein. J Biol Chem 2009; 284:11048 - 58; http://dx.doi.org/10.1074/jbc.M806559200; PMID: 19141614
   PubMed Web of Science ®Google Scholar
• Zhou C, Emadi S, Sierks MR, Messer A. A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein. Mol Ther 2004; 10:1023 - 31; http://dx.doi.org/10.1016/j.ymthe.2004.08.019; PMID: 15564134
   PubMed Web of Science ®Google Scholar
• Emadi S, Liu R, Yuan B, Schulz P, McAllister C, Lyubchenko Y, et al. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments. Biochemistry 2004; 43:2871 - 8; http://dx.doi.org/10.1021/bi036281f; PMID: 15005622
   PubMed Web of Science ®Google Scholar
• Giasson BI, Murray IV, Trojanowski JQ, Lee VM. A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. J Biol Chem 2001; 276:2380 - 6; http://dx.doi.org/10.1074/jbc.M008919200; PMID: 11060312
   PubMed Web of Science ®Google Scholar
• Periquet M, Fulga T, Myllykangas L, Schlossmacher MG, Feany MB. Aggregated alpha-synuclein mediates dopaminergic neurotoxicity in vivo. J Neurosci 2007; 27:3338 - 46; http://dx.doi.org/10.1523/JNEUROSCI.0285-07.2007; PMID: 17376994
   PubMed Web of Science ®Google Scholar
• Lynch SM, Zhou C, Messer A. An scFv intrabody against the nonamyloid component of alpha-synuclein reduces intracellular aggregation and toxicity. J Mol Biol 2008; 377:136 - 47; http://dx.doi.org/10.1016/j.jmb.2007.11.096; PMID: 18237741
   PubMed Web of Science ®Google Scholar
• Dudgeon K, Famm K, Christ D. Sequence determinants of protein aggregation in human VH domains. Protein Eng Des Sel 2009; 22:217 - 20; http://dx.doi.org/10.1093/protein/gzn059; PMID: 18957405
   PubMed Web of Science ®Google Scholar
• Wheeler YY, Chen SY, Sane DC. Intrabody and intrakine strategies for molecular therapy. Mol Ther 2003; 8:355 - 66; http://dx.doi.org/10.1016/S1525-0016(03)00183-7; PMID: 12946308
   PubMed Web of Science ®Google Scholar
• Kuo CL, Oyler GA, Shoemaker CB. Accelerated neuronal cell recovery from Botulinum neurotoxin intoxication by targeted ubiquitination. PLoS One 2011; 6:e20352; http://dx.doi.org/10.1371/journal.pone.0020352; PMID: 21629663
   PubMed Web of Science ®Google Scholar
• Rondon IJ, Marasco WA. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu Rev Microbiol 1997; 51:257 - 83; http://dx.doi.org/10.1146/annurev.micro.51.1.257; PMID: 9343351
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zeng C, Huhalov A, Yao J, Turi TG, Danley D, et al. Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7. J Immunol Methods 1999; 231:207 - 22; http://dx.doi.org/10.1016/S0022-1759(99)00158-1; PMID: 10648939
   PubMed Web of Science ®Google Scholar
• Li X, Zhao X, Fang Y, Jiang X, Duong T, Fan C, et al. Generation of destabilized green fluorescent protein as a transcription reporter. J Biol Chem 1998; 273:34970 - 5; http://dx.doi.org/10.1074/jbc.273.52.34970; PMID: 9857028
   PubMed Web of Science ®Google Scholar
• Leclerc GM, Boockfor FR, Faught WJ, Frawley LS. Development of a destabilized firefly luciferase enzyme for measurement of gene expression. Biotechniques 2000; 29:590 - 1, 594-6, 598 passim; PMID: 10997273
   PubMed Web of Science ®Google Scholar
• Leclerc GM, Boockfor FR, Faught WJ, Frawley LS. Development of a destabilized firefly luciferase enzyme for measurement of gene expression. Biotechniques 2000; 29:590 - 1, 594-6, 598 passim; PMID: 10997273
   PubMed Web of Science ®Google Scholar
• Sibler AP, Courtête J, Muller CD, Zeder-Lutz G, Weiss E. Extended half-life upon binding of destabilized intrabodies allows specific detection of antigen in mammalian cells. FEBS J 2005; 272:2878 - 91; http://dx.doi.org/10.1111/j.1742-4658.2005.04709.x; PMID: 15943819
   PubMed Web of Science ®Google Scholar
• Lecerf JM, Shirley TL, Zhu Q, Kazantsev A, Amersdorfer P, Housman DE, et al. Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington’s disease. Proc Natl Acad Sci U S A 2001; 98:4764 - 9; http://dx.doi.org/10.1073/pnas.071058398; PMID: 11296304
   PubMed Web of Science ®Google Scholar
• Li X, Coffino P. Distinct domains of antizyme required for binding and proteolysis of ornithine decarboxylase. Mol Cell Biol 1994; 14:87 - 92; PMID: 8264655
   PubMed Web of Science ®Google Scholar
• Zhang M, MacDonald AI, Hoyt MA, Coffino P. Proteasomes begin ornithine decarboxylase digestion at the C terminus. J Biol Chem 2004; 279:20959 - 65; http://dx.doi.org/10.1074/jbc.M314043200; PMID: 15016805
   PubMed Web of Science ®Google Scholar